Gapping down
In reaction to disappointing earnings/guidance:
- TLRY -9.9%, IPAR -9.6%, NGL -9.5%, INO -8.4%, OMER -7.6% (also announces stock offering), CNXN -5.8%, ZI -5.3%, RPAY -4.7%, IFF -4.3%, ANGI -3.9%, IAC -3.8%, HALO -3.7%, OXY -3.6%, GOOS -3.3%, XPER -3.2%, NSTG -3%, QLYS -2.8%, BNTX -2.1%, SSL -1.7%, ESPR -1.4%
M&A news:
- BBDC -3.9% (to merge with MVC)
Other news:
- FENC -35.2% (receives complete response letter from the FDA for its new drug application for Pedmark to prevent ototoxicity associated with cisplatin in pediatric patients with localized, non-metastatic, solid tumors)
- MESO -26.4% (provides update on scheduled FDA Advisory committee meeting)
- GTT -5.4% (delays 10-Q filing)
- BBBY -4.7% (lifts suspension of planned debt reduction; also says July comps were posiitve)
- SDGR -4.4% (stock offering)
- OCFT -4.2% (stock offering)
- WTRG -3.8% (stock offering)
- SSTK -3.7% (stock offering)
- NVAX -3.5% (expands partnership with AGC Biologics)
- SPT -2.8% (stock offering)
- ADAP -2.8% (files for $200 mln mixed shelf offering)
- PRFT -2.4% (convertible notes offering)
- AVYA -1.6% (stock offering)
- UPLD -1.4% (stock offering)
- FND -1.4% (stock offering)
- FTK -1.3% (delays 10-Q filing)
- WETF -1.2% (prices offering of $25.0 million aggregate principal amount of its convertible senior notes due 2023 in a private offering)
- LYFT -1% (unfavorable court ruling in California case)
- UBER -0.9% (unfavorable court ruling in California case)
Analyst comments:
- PAAS -5.6% (downgraded to Hold from Buy at Deutsche Bank)
- ZNGA -0.8% (downgraded to Hold from Buy at Berenberg)